Literature DB >> 2368473

[Concentration of thiobarbituric acid-reactive substances (TBARS) in the plasma of patients with atherosclerosis with different localizations and different degrees of severity].

I Schimke1, P Romaniuk, E Schimke, B Papies.   

Abstract

The concentration of thiobarbituric acid reactive substances (TBARS) formed as a result of lipid peroxidation and prostanoid metabolism was measured in the plasma of patients with coronary or peripheric atherosclerosis. From the results conclusions were deduced to the function of reactive O2-species in the atherogenesis. We found in plasma of patients with coronary as well as with peripheric atherosclerosis increased TBARS concentrations dependent on the dimension of atherosclerosis as an index of activation of reactive O2-species formation. The TBARS concentration correlated with the cholesterol and LDL-cholesterol concentration in plasma.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2368473

Source DB:  PubMed          Journal:  Z Med Lab Diagn        ISSN: 0323-5637


  3 in total

1.  Oxidative stress in the human heart is associated with changes in the antioxidative defense as shown after heart transplantation.

Authors:  I Schimke; M Schikora; R Meyer; H P Dübel; D Modersohn; F X Kleber; G Baumann
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

2.  A Prospective Non-Randomized Open-Label Comparative Study of The Effects of Matcha Tea on Overweight and Obese Individuals: A Pilot Observational Study.

Authors:  Tamam El-Elimat; Wala'a M Qasem; Nour A Al-Sawalha; Mahmoud M AbuAlSamen; Ramzi T Munaiem; Reema Al-Qiam; Ahmed H Al Sharie
Journal:  Plant Foods Hum Nutr       Date:  2022-08-03       Impact factor: 4.124

3.  Assessment of oxidative stress markers in elderly patients with SARS-CoV-2 infection and potential prognostic implications in the medium and long term.

Authors:  Nestor Vazquez-Agra; Ana-Teresa Marques-Afonso; Anton Cruces-Sande; Ignacio Novo-Veleiro; Antonio Pose-Reino; Estefania Mendez-Alvarez; Ramon Soto-Otero; Alvaro Hermida-Ameijeiras
Journal:  PLoS One       Date:  2022-10-06       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.